A Study on the Bioequivalence of Bupivacaine Liposome Injection in Humans
Clinical trial NCT07279155 · COMPLETED
Trial details
- NCT number
- NCT07279155
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-09
- Primary completion
- 2025-07-21
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.